List of Excipients in Branded Drug CLARITIN

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Bayer HealthCare LLC	CLARITIN	loratadine	11523-0007	CELLULOSE, MICROCRYSTALLINE
Bayer HealthCare LLC	CLARITIN	loratadine	11523-0007	LACTOSE MONOHYDRATE
Bayer HealthCare LLC	CLARITIN	loratadine	11523-0007	MAGNESIUM STEARATE
Bayer HealthCare LLC	CLARITIN	loratadine	11523-0007	SODIUM STARCH GLYCOLATE TYPE A CORN
Bayer HealthCare LLC	CLARITIN	loratadine	11523-0101	EDETATE DISODIUM
Bayer HealthCare LLC	CLARITIN	loratadine	11523-0101	GLYCERIN

Generic Drugs Containing CLARITIN

Company	Ingredient	NDC	Excipient
Bayer HealthCare LLC	loratadine	11523-0104	ALUMINUM OXIDE
Bayer HealthCare LLC	loratadine	11523-0104	ANHYDROUS CITRIC ACID
Bayer HealthCare LLC	loratadine	11523-0104	ASPARTAME
Bayer HealthCare LLC	loratadine	11523-0104	CELLULOSE, MICROCRYSTALLINE
Bayer HealthCare LLC	loratadine	11523-0104	D&C RED NO. 27
Bayer HealthCare LLC	loratadine	11523-0104	FD&C BLUE NO. 2

What are the Most Frequently-Used Excipients in CLARITIN?

# Of NDCs	Excipient
1	ALUMINUM OXIDE
1	ANHYDROUS CITRIC ACID
1	ASPARTAME
4	CELLULOSE, MICROCRYSTALLINE
1	D&C RED NO. 27
1	FD&C BLUE NO. 2

Excipient Strategy and Commercial Opportunities for Claritin

Last updated: February 26, 2026

What is Claritin’s Formulation Composition?

Claritin (loratadine) is an antihistamine used to treat allergic rhinitis and urticaria. It is available mainly as oral tablets and syrup. The active pharmaceutical ingredient (API) is loratadine, with common excipients including:

• Lactose monohydrate
• Microcrystalline cellulose
• Sodium starch glycolate
• Magnesium stearate
• Hypromellose (in sustained-release formulations)
• Titanium dioxide (as a pigment)
• Talc

The formulation varies by dosage form and manufacturer, often leveraging excipients to optimize bioavailability, stability, and patient experience.

How Do Excipients Affect Claritin’s Performance?

Excipients contribute to:

• Bioavailability: Lactose and microcrystalline cellulose help form a stable matrix, aiding dissolution.
• Stability: Titanium dioxide and magnesium stearate protect against moisture and degradation.
• Patient Compliance: Coloring agents and flavorings improve palatability for syrups.
• Manufacturing: Excipients influence processability, shelf life, and scalability.

The choice of excipients impacts bioequivalence between formulations, shelf stability, and manufacturing cost. For example, replacing lactose with other fillers like xylitol could expand allergy-sensitive markets.

What Are Key Development Trends in Excipient Strategies for Claritin?

• Allergen-Free Formulations: Developing lactose- and talc-free excipients due to patient allergies.
• Improved Solubility and Bioavailability: Using surfactants or solubilizers in formulations.
• Controlled-release Systems: Incorporating hydroxypropyl methylcellulose (HPMC) or similar polymers for sustained release.
• Novel Excipients Deployment: Polymers that enhance stability under varying storage conditions.

What Commercial Opportunities Exist in Excipient Optimization?

Market Size and Growth

The global excipients market reached approximately USD 8.6 billion in 2022, with a compound annual growth rate (CAGR) of 5.5% projected through 2030 ([1]). The demand for specialized excipients, such as allergen-free or controlled-release variants, constitutes a growing segment.

Opportunities for Claritin-specific Excipient Innovations

• Lactose Alternatives: Addressing lactose intolerance and allergy increases market access. Xylitol and mannitol are potential substitutes.
• Flavoring and Coloring: Developing natural, non-artificial flavorings and colorings to meet consumer preference and regulatory trends.
• Sustained-Release Technologies: Patenting formulations with polymers such as hypromellose (HPMC) for once-daily dosing.
• Enhanced Stability Formulations: Incorporating antioxidants or moisture scavengers for improved shelf life.
• Distinction in Generic Markets: Custom excipients enabling generic versions to differentiate on stability, bioavailability, or patient experience.

Regulatory and Manufacturing Considerations

• Use of excipients approved by regulatory agencies (FDA, EMA) limits formulation complexity.
• Novel excipients require extensive safety and compatibility testing.
• Compatibility of excipients with the API, manufacturing processes, and storage conditions influences choice.

What Competitive Landscape Exists?

Major excipient manufacturers include:

• Amcor
• FMC
• Lubrizol
• Evonik
• Colorcon

These suppliers offer a range of excipients suited for antihistamine formulations, including lactose-free and sustained-release options. Collaborations with formulators can lead to proprietary excipient systems tailored for Claritin.

What Next Steps Are Suitable for Stakeholders?

• Conduct formulation research targeting allergen-free excipients.
• Invest in R&D for controlled-release and stability-enhancing excipients.
• Form strategic partnerships with excipient suppliers for customized solutions.
• Monitor regulatory landscapes for new excipient approvals that could ease market entry or expand indications.

Key Takeaways

• Excipient choices critically influence Claritin’s formulation performance, patient adherence, and manufacturing efficiency.
• The market for innovative excipients is expanding, driven by demand for allergen-free, stable, and controlled-release formulations.
• Companies can differentiate through proprietary excipient systems, particularly in the generic space.
• Regulatory compliance remains pivotal in excipient development, especially concerning new or novel agents.
• The growing global excipients market offers opportunities in developing next-generation formulation components for Claritin.

FAQs

1. Can allergen-free excipients expand Claritin’s market?
Yes. Replacing lactose and talc with allergen-free alternatives can attract lactose-intolerant and allergy-sensitive consumers.

2. What are the barriers to using novel excipients in Claritin formulations?
Regulatory approval processes and the need for extensive safety data limit rapid adoption of new excipients.

3. How does controlled-release technology impact Claritin's dosing?
It allows for once-daily dosing, improving patient adherence and expanding market reach.

4. Are natural excipients gaining favor in antihistamine formulations?
Yes. Natural flavorings and colorings meet consumer preferences and regulatory requirements for clean-label products.

5. What are the key considerations in excipient selection for flavored Claritin syrups?
Taste masking capabilities, compatibility with active ingredients, stability, and regulatory approval status.

---

References

[1] MarketsandMarkets. (2022). Excipients Market by Source, Type, Function, and Region: Global Forecast to 2030.